In accordance, recently other genes such as KDM5D and KDM6A have been associated with the tumor microenvironment based on sex differences for colon cancer and GBM, respectively.8,35 These articles emphasize the need to determine sex differences as this greatly affects the response to immunotherapies. This evidence concerns the gene KDM5D and malignant colon neoplasm.